Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate UpdatePRNewsWire • 06/27/24
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024PRNewsWire • 06/21/24
Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer TrialPRNewsWire • 06/18/24
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVIDNewsfile Corp • 06/03/24
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment StudiesPRNewsWire • 06/03/24
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient PlasmaPRNewsWire • 05/10/24
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture DevicesPRNewsWire • 02/21/24
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 02/14/24
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024PRNewsWire • 02/07/24
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/14/23
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023PRNewsWire • 11/06/23
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in OncologyPRNewsWire • 10/10/23
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment ConferencePRNewsWire • 08/30/23
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 08/10/23
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023PRNewsWire • 08/03/23